These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23759381)

  • 21. Diclofenac salts, part 6: release from lipid microspheres.
    Fini A; Cavallari C; Rabasco Alvarez AM; Rodriguez MG
    J Pharm Sci; 2011 Aug; 100(8):3482-3494. PubMed ID: 21523784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hot melt extruded zein for controlled delivery of diclofenac sodium: Effect of drug loading and medium composition.
    Bisharat L; Alkhatib HS; Abdelhafez A; Barqawi A; Aljaberi A; Qi S; Berardi A
    Int J Pharm; 2020 Jul; 585():119503. PubMed ID: 32502688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Hydrogenated Soybean Phosphatidylcholine Matrices Prepared by Hot Melt Extrusion for Oral Controlled Delivery of Water-Soluble Drugs.
    Kolbina M; Schulte A; van Hoogevest P; Körber M; Bodmeier R
    AAPS PharmSciTech; 2019 Apr; 20(4):159. PubMed ID: 30968304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
    Rahman Z; Zidan AS; Khan MA
    Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous manufacturing of solid lipid nanoparticles by hot melt extrusion.
    Patil H; Kulkarni V; Majumdar S; Repka MA
    Int J Pharm; 2014 Aug; 471(1-2):153-6. PubMed ID: 24853459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acids for controlled release applications: A comparison between prilling and solid lipid extrusion as manufacturing techniques.
    Vervaeck A; Monteyne T; Siepmann F; Boone MN; Van Hoorebeke L; De Beer T; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):173-84. PubMed ID: 26428938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of design of experiments to develop hot melt extrudates for extended release of diclofenac sodium.
    Sanoufi MR; Aljaberi A; Hamdan I; Al-Zoubi N
    Pharm Dev Technol; 2020 Feb; 25(2):187-196. PubMed ID: 31637932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid lipid extrudates as sustained-release matrices: the effect of surface structure on drug release properties.
    Reitz C; Strachan C; Kleinebudde P
    Eur J Pharm Sci; 2008 Nov; 35(4):335-43. PubMed ID: 18765281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
    Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
    Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of hot-melt extrusion on the tableting behaviour of polyvinyl alcohol.
    Grymonpré W; De Jaeghere W; Peeters E; Adriaensens P; Remon JP; Vervaet C
    Int J Pharm; 2016 Feb; 498(1-2):254-62. PubMed ID: 26691654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion.
    Almeida A; Possemiers S; Boone MN; De Beer T; Quinten T; Van Hoorebeke L; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2011 Feb; 77(2):297-305. PubMed ID: 21168487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.
    Djuris J; Nikolakakis I; Ibric S; Djuric Z; Kachrimanis K
    Eur J Pharm Biopharm; 2013 May; 84(1):228-37. PubMed ID: 23333900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the possible relationship between the drug release of Compritol®-containing tablets and its polymorph forms using micro X-ray diffraction.
    Jannin V; Rosiaux Y; Doucet J
    J Control Release; 2015 Jan; 197():158-64. PubMed ID: 25445699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of metoprolol tartrate multiple-unit lipid matrix systems produced by different technologies.
    Aleksovski A; Van Bockstal PJ; Roškar R; Sovány T; Regdon G; De Beer T; Vervaet C; Dreu R
    Eur J Pharm Sci; 2016 Jun; 88():233-45. PubMed ID: 26980237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.
    Feng J; Xu L; Gao R; Luo Y; Tang X
    Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid.
    Bruce LD; Shah NH; Malick AW; Infeld MH; McGinity JW
    Eur J Pharm Biopharm; 2005 Jan; 59(1):85-97. PubMed ID: 15567305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A preliminary assessment of the impact of hot-melt extrusion on the physico-mechanical properties of a tablet.
    Boersen N; Lee TW; Shen XG; Hui HW
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1386-94. PubMed ID: 23957611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.